MedPath

Comparison the effect of Single Dose versus Divided Dose of ASA on endothelial function in diabetic patients (Type2): A Randomized Clinical Trial

Phase 3
Recruiting
Conditions
ewly diagnosed Diabetes mellitus without complication.
Type 2 diabetes mellitus without complications
E11.9
Registration Number
IRCT20191101045301N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Age more than 40 year
Diabetes Melitus
ASCVD Score more than 7.5

Exclusion Criteria

Any cardiovascular disease
Any cerebrovascular disease
Any cardiac arrhythmia
Any anti platelet or anticoagulant consumption
Suffering from acute or chronic infection
Platelet disturbance or bleeding tendency
NSAIDs consumption in recent 14 days
Platelet count less than 120000
Smoking
Chronic Kidney Disease (CKD)
GI Bleeding
Pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Flow Mediated Dilation. Timepoint: Bse line, 1 hour after treatment,6 days after treatment( one hour before last dose), 6 days after treatment( one hour after last dose). Method of measurement: Echocardiography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath